Vr Adviser, LLC Trevi Therapeutics, Inc. Transaction History
Vr Adviser, LLC
- $1.17 Billion
- Q1 2024
A detailed history of Vr Adviser, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 3,422,675 shares of TRVI stock, worth $9.17 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
3,422,675
Previous 3,422,397
0.01%
Holding current value
$9.17 Million
Previous $4.59 Million
157.48%
% of portfolio
1.01%
Previous 0.56%
Shares
3 transactions
Others Institutions Holding TRVI
# of Institutions
79Shares Held
50.5MCall Options Held
2.2KPut Options Held
600-
Nea Management Company, LLC Timonium, MD11.4MShares$30.5 Million2.75% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$19.8 Million1.34% of portfolio
-
Rubric Capital Management LP New York, NY5.56MShares$14.9 Million0.65% of portfolio
-
Viking Global Investors LP4.4MShares$11.8 Million0.06% of portfolio
-
Opaleye Management Inc. Boston, MA2.65MShares$7.09 Million2.22% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $156M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...